Primary and acquired immunodeficiencies like HIV/AIDS are associated with a high prevalence of skin and mucosal diseases caused by the Human Papillomaviruses (HPV), as well as an accelerated progression to HPV-related cancers. Dr. Lisco`s primary focus is on delineating the genetic, immunological, and molecular determinants of the persistence, regression, or progression of HPV-related diseases to inform innovative preventive and therapeutic strategies. The translational workflow of the laboratory is based on the integration of clinical protocols focused on the identification of clinical and epidemiological predictors of severe HPV-related diseases with studies on host genetics and tissue-specific immunopathogenesis at the skin and mucosal barriers, eventually informing personalized interventional clinical protocols.
Andrea Lisco, M.D., Ph.D.
Chief, Mucosal and Cutaneous Viral Immunopathogenesis Unit
Lasker Clinical Research Scholar
Contact: For contact information, search the NIH Enterprise Directory.
Education:
M.D., University of Bari, Italy
Ph.D., University of Padua, Italy
Derek MacMath, M.D.
Clinical Fellow
Contact: For contact information, search the NIH Enterprise Directory.
Education:
B.S., 2014, Molecular and Cellular Biology, Italian, Johns Hopkins University, Baltimore, MD
M.D., 2019, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
Internal Medicine/Pediatrics Residency, 2023, Baylor College of Medicine/Texas Children’s Hospital, Houston, TX
Amay Shah, B.S.
Postbaccalaureate IRTA Fellow
Contact: For contact information, search the NIH Enterprise Directory.
Education:
B.S., 2023, Human Biology and Society + Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles
Peiying Ye, Ph.D.
Biologist
Contact: For contact information, search the NIH Enterprise Directory.
Languages Spoken: Chinese
